International Journal of Health Economics and Management

2004 - 2024

Current editor(s): Leemore Dafny, Robert Town, Mark Pauly, David Dranove and Pedro Pita Barros

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 9, issue 4, 2009

The effect of physicians’ remuneration system on the Caesarean section rate: the Uruguayan case pp. 333-345

Patricia Triunfo and Maximo Rossi

Which preferred providers are really preferred? Effectiveness of insurers’ channeling incentives on pharmacy choice pp. 347-366

Lieke Boonen, Frederik Schut, Bas Donkers and Xander Koolman

Health insurance and ex ante moral hazard: evidence from Medicare pp. 367-390

Dhaval Dave and Robert Kaestner

Population ageing and its implications on aggregate health care demand: empirical evidence from 22 OECD countries pp. 391-402

Alfons Palangkaraya and Jongsay Yong

The convergence between for-profit and nonprofit hospitals in the United States pp. 403-428

Guy David

Volume 9, issue 3, 2009

The potential premium range of risk-rating in competitive markets for supplementary health insurance pp. 243-258

Francesco Paolucci, Femmeke Prinsze, Pieter Stam and Wynand Ven

Incentives and remuneration systems in dental services pp. 259-278

Jostein Grytten, Dorthe Holst and Irene Skau

The variance of length of stay and the optimal DRG outlier payments pp. 279-289

Stefan Felder

Generic script share and the price of brand-name drugs: the role of consumer choice pp. 291-316

John Rizzo and Richard Zeckhauser

An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography pp. 317-332

Paolo Pertile

Volume 9, issue 2, 2009

Provider payment incentives: international comparisons pp. 113-115

Karen Eggleston

The soft budget constraint syndrome in the hospital sector pp. 117-135

János Kornai

The healer or the druggist: effects of two health care policies in Taiwan on elderly patients’ choice between physician and pharmacist services pp. 137-152

Simon Chang

Does your health care depend on how your insurer pays providers? Variation in utilization and outcomes in Thailand pp. 153-168

Sanita Hirunrassamee and Sauwakon Ratanawijitrasin

Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry pp. 169-182

Zhe Zhang, Ming Jia and Difang Wan

Has the use of physician gatekeepers declined among HMOs? Evidence from the United States pp. 183-195

Hai Fang, Hong Liu and John Rizzo

An economic analysis of payment for health care services: The United States and Switzerland compared pp. 197-210

Peter Zweifel and Ming Tai-Seale

The effect of soft budget constraints on access and quality in hospital care pp. 211-232

Yu-Chu Shen and Karen Eggleston

Soft budget constraints in China: Evidence from the Guangdong hospital industry pp. 233-242

Karen Eggleston, Yu-Chu Shen, Mingshan Lu, Congdong Li, Jian Wang, Zhe Yang and Jing Zhang

Volume 9, issue 1, 2009

Why U.S. health care expenditure and ranking on health care indicators are so different from Canada’s pp. 1-24

A. Spithoven

International competition and the demand for health insurance in the US: evidence from the Texas–Mexico border region pp. 25-38

Henry Brown, José Pagán and Elena Bastida

Service motives and profit incentives among physicians pp. 39-57

Geir Godager, Tor Iversen and Ching-to Ma

Nothing for something? Estimating cost and value for beneficiaries from recent medicare spending increases on HMO payments and drug benefits pp. 59-81

Steven Pizer, Austin Frakt and Roger Feldman

Utilisation of physician services in the 50+ population: the relative importance of individual versus institutional factors in 10 European countries pp. 83-112

Kristian Bolin, Anna Lindgren, Björn Lindgren and Petter Lundborg

Volume 8, issue 4, 2008

Consumer price sensitivity in Dutch health insurance pp. 225-244

Machiel Dijk, Marc Pomp, Rudy Douven, Trea Laske-Aldershof, Erik Schut, Willem Boer and Anne Boo

The optimality of hospital financing system: the role of physician–manager interactions pp. 245-256

David Crainich, Hervé Leleu and Ana Mauleon

Run for cover now or later? The impact of premiums, threats and deadlines on private health insurance in Australia pp. 257-277

Randall Ellis and Elizabeth Savage

The physician-patient relationship revisited: the patient’s view pp. 279-300

Udo Schneider and Volker Ulrich

On international cost-sharing of pharmaceutical R&D pp. 301-312

Pedro Barros and Xavier Martinez-Giralt

Volume 8, issue 3, 2008

Information vs advertising in the market for hospital care pp. 145-162

Marcello Montefiori

Are prenatal care resources distributed efficiently across high-risk and low-risk mothers? pp. 163-179

Sankar Mukhopadhyay and Jeanne Wendel

Early discharge and home intervention reduces unit costs after total hip replacement: results of a cost analysis in a randomized study pp. 181-192

Eyjólfur Sigurðsson, Kristin Siggeirsdottir, Halldor Jonsson, Vilmundur Gudnason, Þórólfur Matthíasson and Brynjolfur Jonsson

A model to decompose the performance of supplementary private health insurance markets pp. 193-208

Reiner Leidl

The effect of tax subsidies on high health care expenditure burdens in the United States pp. 209-223

Thomas Selden

Volume 8, issue 2, 2008

The optimal negligence standard in health care under supply-side cost sharing pp. 73-85

Anja Olbrich

The production of published research by U.S. academic health economists pp. 87-111

Michael Morrisey and John Cawley

Bridging the gap between health and non-health investments: moving from cost-effectiveness analysis to a return on investment approach across sectors of economy pp. 113-121

Pedram Sendi

Regional variations in medical expenditure and hospitalization days for heart attack patients in Japan: evidence from the Tokai Acute Myocardial Study (TAMIS) pp. 123-144

Haruko Noguchi, Satoshi Shimizutani and Yuichiro Masuda

Volume 8, issue 1, 2008

Do health insurers possess monopsony power in the hospital services industry? pp. 1-11

Laurie Bates and Rexford Santerre

The effect of physician and health plan market concentration on prices in commercial health insurance markets pp. 13-26

John Schneider, Pengxiang Li, Donald Klepser, N. Peterson, Timothy Brown and Richard Scheffler

Can a violation of investor trust lead to financial contagion in the market for tax-exempt hospital bonds? pp. 27-51

Patrick Bernet and Thomas Getzen

The level of hospital charges and the income of the uninsured patient pp. 53-72

William Lynk and Rachelle Alcain

Volume 7, issue 4, 2007

The organization and financing of dialysis and kidney transplantation services in New Zealand pp. 233-252

Toni Ashton and Mark Marshall

The organization and financing of end-stage renal disease in Spain pp. 253-267

José Luño

The financing and organization of medical care for patients with end-stage renal disease in Sweden pp. 269-281

Björn Wikström, Michael Fored, Margaret Eichleay and Stefan Jacobson

International Study of Health Care Organization and Financing of renal services in England and Wales pp. 283-299

Tricia Nicholson and Paul Roderick

The organization and financing of kidney dialysis and transplant care in the United States of America pp. 301-318

Richard Hirth

Volume 7, issue 2, 2007

End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF) pp. 73-111

Avi Dor, Mark Pauly, Margaret Eichleay and Philip Held

The organization and funding of the treatment of end-stage renal disease in Australia pp. 113-132

Anthony Harris

Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease pp. 133-148

Wim Biesen, Norbert Lameire, Patrick Peeters and Raymond Vanholder

The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care pp. 149-169

Braden Manns, David Mendelssohn and Kenneth Taub

International Study of Health Care Organization and Financing for end-stage renal disease in France pp. 171-183

Isabelle Durand-Zaleski, Christian Combe and Philippe Lang

International study of health care organization and financing: development of renal replacement therapy in Germany pp. 185-200

Werner Kleophas and Helmut Reichel

International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality pp. 201-215

Giuseppe Pontoriero, Pietro Pozzoni, Lucia Vecchio and Francesco Locatelli

The organization and financing of end-stage renal disease treatment in Japan pp. 217-231

Shunichi Fukuhara, Chikao Yamazaki, Yasuaki Hayashino, Takahiro Higashi, Margaret Eichleay, Takashi Akiba, Tadao Akizawa, Akira Saito, Friedrich Port and Kiyoshi Kurokawa

Volume 7, issue 1, 2007

Differential impacts of public health insurance expansions at the local level pp. 1-22

Reagan Baughman

Modeling and detecting potentially ruinous streaks in health expenditures pp. 23-42

Joseph Koopmeiners, Bryan Dowd and Bradley Carlin

Does risk equalization reduce the viability of voluntary deductibles? pp. 43-58

R. Kleef, K. Beck, W. Ven and R. Vliet

Market power and state costs of HIV/AIDS drugs pp. 59-71

Arleen Leibowitz and Neeraj Sood